OXULAR ACQUISITIONS LIMITED

Company number 12798969 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£470,354

Balance sheet as at 2025-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2020-08-07
Employees
1 (2025 accounts · was 0 in 2023)
Registered office
The Charter Building, Vine Street, Uxbridge, Middlesex, England, UB8 1JG
Postcode
UB8 1JG
Accounts category
Small

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-08-03
Next due by
2027-08-17
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 3 current · 7 resigned

Subscribers only Director
Subscribers only Appointed 2024-12-20
Subscribers only Director
Appointed 2024-12-20
Subscribers only Director
Appointed 2020-08-07

View all officers and resignations →

Group structure

Controlled by Regeneron Pharmaceuticals, Inc (01226128) — since 2024-12-20

Controlled by OXULAR LIMITED — since 2020-08-07

From persons-with-significant-control filings on the public register.

Contact details

Website
oxular.net

At this address

140

companies are registered at this postcode →

Competitors Hayes

This company ranks 7 among research and experimental development on biotechnology in Hayes.

Full league table →

The class of 2020

39%

of the 593 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →